N
N

NetEase

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

China to import 27 new video games, including Tencent, NetEase titles

UPDATE 2-China to import 27 new video games, including Tencent, NetEase titles Adds Bilibili and XD have received approval By Josh Ye HONG KONG, March 20 - China's online gaming regulator on Monday granted licences to 27 foreign games in March, including titles to be published by Tencent Holdings 0700.HK , NetEase Inc 9999.HK and Bilibili Inc 9626.HK .
N

China to import 27 new video games including titles to Tencent and NetEase

China to import 27 new video games including titles to Tencent and NetEase By Josh Ye HONG KONG, March 20 - China's online gaming regulator on Monday granted licences to 27 foreign games in March including titles to be published by Tencent Holdings 0700.HK and NetEase 9999.HK . This marks the second batch of foreign online games to have received publishing licences in China in just three months after the regulator approved the first batch in December.
N

Chinese firms working on ChatGPT-style technology

FACTBOX-Chinese firms working on ChatGPT-style technology Adds details on Baidu chatbot March 16 (Reuters) - The global buzz around Microsoft chatbot has spread to China , shoring up stocks in artificial intelligence (AI) related firms and prompting a flurry of local companies to announce rival projects. Like Microsoft and Google,Chinese tech giants such as Baidu BIDU.O and Alibaba 9988.HK as well as smaller start-ups have been working on AI projects for years.
A
B
G
M
N

U.S. STOCKS CrowdStrike, Dentsply Sirona, Qualtrics

BUZZ-U.S. STOCKS ON THE MOVE-CrowdStrike, Dentsply Sirona, Qualtrics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes rose on Monday as Treasury yields pulled back further ahead of Federal Reserve Chair Jerome Powell's testimony and jobs data this week that could offer fresh cues on the trajectory of interest rates.
A
A
C
F
I
I
N
S
T
D
U
U

U.S. STOCKS Tesla, BridgeBio, Unicycive Therapeutics, Allbirds

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, BridgeBio, Unicycive Therapeutics, Allbirds Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were set to open higher on Monday as Treasury yields retreated further, ahead of Federal Reserve Chair Jerome Powell's testimony and jobs data this week that could offer fresh cues on the trajectory of interest rates.
A
A
F
I
I
N
T
D
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.